XVIVO Perfusion_NIHP-001_PRESERVE Heart Study

What is the Purpose of this Study?

The primary objective is to demonstrate the effectiveness at 30-days post heart transplantation, and an acceptable long-term safety profile of the XVIVO Heart Preservation System.


Eligibility

  • 1. Age ≥18 years.
  • 2. Signed informed consent form (ICF).
  • 3. Listed for heart transplantation
Show more

Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

A Prospective, Multi-center, Single-Arm, Open- label Study of Hearts Transplanted after Non-Ischemic Heart PRESERVation from Extended Donors

Study Details
Disease Type/Condition

Other

Principal Investigator

Esmailian, Fardad

Age Group

Adult

Phase

N/A

IRB Number

STUDY00003095

ClinicalTrials.gov ID

NCT05881278

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Esmailian, Fardad

Age Group

Adult

Phase

N/A

IRB Number

NIHP-001

ClinicalTrials.gov ID

NCT05881278

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org